Thompson Davis & Co’s Amgen AMGN Stock Holding History

Thompson Davis & Co’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$21K	Buy	+100	New	+$19.7K	0.05%	316
2017 Q4	–	Sell	-165	Closed	-$31K	–	684
2017 Q3	$31K	Sell	165 -72	-30%	-$12.8K	0.05%	342
2017 Q2	$41K	Buy	237 +73	+45%	+$11.9K	0.07%	256
2017 Q1	$27K	Hold	164	–	–	0.04%	389
2016 Q4	$24K	Hold	164	–	–	0.04%	427
2016 Q3	$27K	Sell	164 -165	-50%	-$27.9K	0.05%	378
2016 Q2	$50K	Hold	329	–	–	0.08%	238
2016 Q1	$49K	Buy	329 +128	+64%	+$19K	0.07%	243
2015 Q4	$33K	Hold	201	–	–	0.05%	332
2015 Q3	$28K	Buy	201 +41	+26%	+$6.46K	0.04%	369
2015 Q2	$25K	Hold	160	–	–	0.03%	482
2015 Q1	$26K	Buy	+160	New	+$25.2K	0.03%	462
2014 Q4	–	Sell	-724	Closed	-$102K	–	1164
2014 Q3	$102K	Buy	+724	New	+$94.5K	0.13%	161

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Thompson Davis & Co's AMGN Position: Q3 2018 in Review

Thompson Davis & Co opened a new position in Amgen (AMGN) in Q3 2018: 100 shares worth $21K. The stake represents 0.05% of the portfolio and ranks #316 among its holdings. This is a return to the name: Thompson Davis & Co previously reported a position in AMGN as recently as Q3 2017.

Thompson Davis & Co first reported a position in AMGN in Q3 2014 and has held it in 13 quarters since. The position peaked at $102K in Q3 2014. 1,796 funds tracked by Wall St. Rank hold AMGN as of Q3 2018.

Thompson Davis & Co held 100 shares of Amgen worth $21K as of Q3 2018.
Amgen was a new Thompson Davis & Co position in Q3 2018.
Amgen made up 0.05% of Thompson Davis & Co's portfolio in Q3 2018, its #316 holding.
Thompson Davis & Co first reported a position in Amgen in Q3 2014 and has held it in 13 quarters since.
Thompson Davis & Co's Amgen position peaked at $102K in Q3 2014.
1,796 funds tracked by Wall St. Rank held Amgen as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.